132 related articles for article (PubMed ID: 17048295)
1. Aryl indanyl ketones: efficient inhibitors of the human peptidyl prolyl cis/trans isomerase Pin1.
Daum S; Erdmann F; Fischer G; Féaux de Lacroix B; Hessamian-Alinejad A; Houben S; Frank W; Braun M
Angew Chem Int Ed Engl; 2006 Nov; 45(44):7454-8. PubMed ID: 17048295
[No Abstract] [Full Text] [Related]
2. Aryl hetaryl ketones and thioketones as efficient inhibitors of peptidyl-prolyl cis-trans isomerases.
Hediger T; Frank W; Schumann M; Fischer G; Braun M
Chem Biodivers; 2012 Nov; 9(11):2618-34. PubMed ID: 23161639
[TBL] [Abstract][Full Text] [Related]
3. Convergent synthesis of alpha-ketoamide inhibitors of Pin1.
Xu GG; Etzkorn FA
Org Lett; 2010 Feb; 12(4):696-9. PubMed ID: 20102178
[TBL] [Abstract][Full Text] [Related]
4. Nanomolar inhibitors of the peptidyl prolyl cis/trans isomerase Pin1 from combinatorial peptide libraries.
Wildemann D; Erdmann F; Alvarez BH; Stoller G; Zhou XZ; Fanghänel J; Schutkowski M; Lu KP; Fischer G
J Med Chem; 2006 Apr; 49(7):2147-50. PubMed ID: 16570909
[TBL] [Abstract][Full Text] [Related]
5. [Pin1: a multi-talented peptidyl prolyl cis-trans isomerase and a promising therapeutic target for human cancers].
Marsolier J; Weitzman JB
Med Sci (Paris); 2014; 30(8-9):772-8. PubMed ID: 25174754
[TBL] [Abstract][Full Text] [Related]
6. Structure-based design of novel human Pin1 inhibitors (I).
Guo C; Hou X; Dong L; Dagostino E; Greasley S; Ferre R; Marakovits J; Johnson MC; Matthews D; Mroczkowski B; Parge H; Vanarsdale T; Popoff I; Piraino J; Margosiak S; Thomson J; Los G; Murray BW
Bioorg Med Chem Lett; 2009 Oct; 19(19):5613-6. PubMed ID: 19729306
[TBL] [Abstract][Full Text] [Related]
7. [Design, synthesis and biological evaluation of novel diaryl ethers bearing a pyrimidine motif as human Pin1 inhibitors].
Xi YY; Jin J; Sun Y; Chen XG; Song HR; Xu BL
Yao Xue Xue Bao; 2013 Aug; 48(8):1266-72. PubMed ID: 24187834
[TBL] [Abstract][Full Text] [Related]
8. [Recent advances in the study of pin1 and its inhibitors].
Zhang CJ; Zhang ZH; Xu BL; Wang YL
Yao Xue Xue Bao; 2008 Jan; 43(1):9-17. PubMed ID: 18357725
[TBL] [Abstract][Full Text] [Related]
9. Conformation-directed catalysis and coupled enzyme-substrate dynamics in Pin1 phosphorylation-dependent cis-trans isomerase.
Velazquez HA; Hamelberg D
J Phys Chem B; 2013 Oct; 117(39):11509-17. PubMed ID: 23980573
[TBL] [Abstract][Full Text] [Related]
10. Novel spiroannulated 3-benzofuranones. Synthesis and inhibition of the human peptidyl prolyl cis/trans isomerase Pin1.
Braun M; Hessamian-Alinejad A; de Lacroix BF; Alvarez BH; Fischer G
Molecules; 2008 Apr; 13(4):995-1003. PubMed ID: 18463601
[TBL] [Abstract][Full Text] [Related]
11. A Selective, Cell-Permeable Nonphosphorylated Bicyclic Peptidyl Inhibitor against Peptidyl-Prolyl Isomerase Pin1.
Jiang B; Pei D
J Med Chem; 2015 Aug; 58(15):6306-12. PubMed ID: 26196061
[TBL] [Abstract][Full Text] [Related]
12. Peptidyl prolyl isomerase Pin1-inhibitory activity of D-glutamic and D-aspartic acid derivatives bearing a cyclic aliphatic amine moiety.
Nakagawa H; Seike S; Sugimoto M; Ieda N; Kawaguchi M; Suzuki T; Miyata N
Bioorg Med Chem Lett; 2015 Dec; 25(23):5619-24. PubMed ID: 26508545
[TBL] [Abstract][Full Text] [Related]
13. Role of prolyl isomerase pin1 in pathogenesis of diseases and remedy for the diseases from natural products.
Takahashi K; Shimizu T; Kosaka K; Hidaka M; Uchida C; Uchida T
Curr Drug Targets; 2014; 15(10):973-81. PubMed ID: 25182609
[TBL] [Abstract][Full Text] [Related]
14. Conformationally locked isostere of phosphoSer-cis-Pro inhibits Pin1 23-fold better than phosphoSer-trans-Pro isostere.
Wang XJ; Xu B; Mullins AB; Neiler FK; Etzkorn FA
J Am Chem Soc; 2004 Dec; 126(47):15533-42. PubMed ID: 15563182
[TBL] [Abstract][Full Text] [Related]
15. Structure-guided design of alpha-amino acid-derived Pin1 inhibitors.
Potter AJ; Ray S; Gueritz L; Nunns CL; Bryant CJ; Scrace SF; Matassova N; Baker L; Dokurno P; Robinson DA; Surgenor AE; Davis B; Murray JB; Richardson CM; Moore JD
Bioorg Med Chem Lett; 2010 Jan; 20(2):586-90. PubMed ID: 19969456
[TBL] [Abstract][Full Text] [Related]
16. Substrate-based design of reversible Pin1 inhibitors.
Zhang Y; Füssel S; Reimer U; Schutkowski M; Fischer G
Biochemistry; 2002 Oct; 41(39):11868-77. PubMed ID: 12269831
[TBL] [Abstract][Full Text] [Related]
17. The peptidyl-prolyl isomerase Pin1.
Joseph JD; Yeh ES; Swenson KI; Means AR; Winkler
Prog Cell Cycle Res; 2003; 5():477-87. PubMed ID: 14593743
[TBL] [Abstract][Full Text] [Related]
18. Thermodynamics of phosphopeptide binding to the human peptidyl prolyl cis/trans isomerase Pin1.
Daum S; Fanghänel J; Wildemann D; Schiene-Fischer C
Biochemistry; 2006 Oct; 45(39):12125-35. PubMed ID: 17002312
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for high-affinity peptide inhibition of human Pin1.
Zhang Y; Daum S; Wildemann D; Zhou XZ; Verdecia MA; Bowman ME; Lücke C; Hunter T; Lu KP; Fischer G; Noel JP
ACS Chem Biol; 2007 May; 2(5):320-8. PubMed ID: 17518432
[TBL] [Abstract][Full Text] [Related]
20. A dual inhibitor against prolyl isomerase Pin1 and cyclophilin discovered by a novel real-time fluorescence detection method.
Mori T; Hidaka M; Lin YC; Yoshizawa I; Okabe T; Egashira S; Kojima H; Nagano T; Koketsu M; Takamiya M; Uchida T
Biochem Biophys Res Commun; 2011 Mar; 406(3):439-43. PubMed ID: 21333629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]